All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Antineoplastic agents;Protein kinase inhibitors

Lorviqua

(lorlatinib)

Uses, side effects, dosage information & price range

Pfizer Europe MA EEIG

About this medicine

Lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)?positive advanced non?small cell lung cancer (NSCLC) previously not treated with an ALK inhibitor. Lorviqua as monotherapy is indicated for the treatment of adult patients with ALK?positive advanced NSCLC whose disease has progressed after: alectinib or ceritinib as the first ALK tyrosine kinase inhibitor (TKI) therapy; or crizotinib and at least one other ALK TKI.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

IclusigComposition: ponatinibIncyte Biosciences Distribution B.V.
Price on RequestView Details →
ItovebiComposition: inavolisibRoche Registration GmbH
Price on RequestView Details →
StivargaComposition: regorafenibBayer Pharma AG
Price on RequestView Details →
Imatinib TevaComposition: imatinibTeva B.V.
Price on RequestView Details →
ImbruvicaComposition: ibrutinibJanssen-Cilag International NV
Price on RequestView Details →

Key Information

Salt / Composition

lorlatinib

Category

Antineoplastic agents;Protein kinase inhibitors

Manufacturer

Pfizer Europe MA EEIG

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.